Cargando…

Higher Proportion of Non-1-84 PTH Fragments in Peritoneal Dialysis Patients Compared to Hemodialysis Patients Using Solutions Containing 1.75 mmol/l Calcium

Background: The prevalence of low- turnover bone disease (LTBD) in peritoneal dialysis (PD) patients is higher than in hemodialysis (HD) patients. LTBD patients may be at risk for vascular calcification, and cardiovascular disease. Current therapy for chronic kidney disease metabolic bone disorders...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-González, Carmen, Gonzalez-Casaus, Maria Luisa, Sellares, Víctor Lorenzo, Albalate, Marta, Torregrosa, José-Vicente, Mas, Sebastian, Ortiz, Alberto, Rodriguez, Mariano, Gonzalez-Parra, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262178/ https://www.ncbi.nlm.nih.gov/pubmed/30524306 http://dx.doi.org/10.3389/fphys.2018.01643

Ejemplares similares

Long-term effects on PTH and mineral metabolism of 1.25 versus 1.75 mmol/L dialysate calcium in peritoneal dialysis patients: a meta-analysis
por: Jin, Liqin, et al.
Publicado: (2019)

Comparing the values of intact parathormone and 1– 84 PTH to predict hyperparathyroidism in hemodialysis patients
por: Jenabi, Aria, et al.
Publicado: (2017)

Use of rhPTH(1-84) for hypoparathyroidism during early pregnancy and lactation
por: Liao, E Pauline, et al.
Publicado: (2023)

KNb(1.75)V(0.25)PS(10)
por: Yu, Jaemin, et al.
Publicado: (2011)

The SUPERFAMILY 1.75 database in 2014: a doubling of data
por: Oates, Matt E., et al.
Publicado: (2014)

In Vitro Effects of PTH (1-84) on Human Skeletal Muscle-Derived Satellite Cells
por: Romagnoli, Cecilia, et al.
Publicado: (2023)

Would raising the total cholesterol diagnostic cut-off from 7.5 mmol/L to 9.3 mmol/L improve detection rate of patients with monogenic familial hypercholesterolaemia?
por: Futema, M., et al.
Publicado: (2015)

OR07-03 Continuous Subcutaneous Delivery of RhPTH(1-84) by Pump in Adults with Hypoparathyroidism
por: Bove-Fenderson, Erin, et al.
Publicado: (2020)

Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1–84) treatment
por: Marcucci, G., et al.
Publicado: (2022)

SUPERFAMILY 1.75 including a domain-centric gene ontology method
por: de Lima Morais, David A., et al.
Publicado: (2011)

Nanoscale phase separation of antiferromagnetic order and superconductivity in K(0.75)Fe(1.75)Se(2)
por: Yuan, R. H., et al.
Publicado: (2012)

1,25-Dihydroxyvitamin D to PTH(1–84) Ratios Strongly Predict Cardiovascular Death in Heart Failure
por: Gruson, Damien, et al.
Publicado: (2015)

Band Structure of Topological Insulator BiSbTe(1.25)Se(1.75)
por: Lohani, H., et al.
Publicado: (2017)

Safety and Efficacy of PTH 1‐34 and 1‐84 Therapy in Chronic Hypoparathyroidism: A Meta‐Analysis of Prospective Trials
por: Puliani, Giulia, et al.
Publicado: (2022)

Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1–84)
por: Chen, Kristina S, et al.
Publicado: (2020)

Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
por: Pietrogrande, Luca
Publicado: (2010)

Use of Lifestyle Modifications for Management of a Patient with Severely High Total Cholesterol (> 14 mmol/L) and Triglycerides (> 40 mmol/L)
por: Patel, Janhavi, et al.
Publicado: (2021)

A 63 element 1.75 dimensional ultrasound phased array for the treatment of benign prostatic hyperplasia
por: Saleh, Khaldon Y, et al.
Publicado: (2005)

A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients
por: Villa-Bellosta, Ricardo, et al.
Publicado: (2017)

OR21-1 The PaTH Forward Trial: Efficacy and Safety of TransCon PTH Through Week 84 for Adults With Hypoparathyroidism
por: Ahmed, Intekhab, et al.
Publicado: (2022)

Effects of parathyroid hormone rhPTH(1–84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study
por: Clarke, Bart L., et al.
Publicado: (2016)

Serum Calcium Levels in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort
por: Rejnmark, Lars, et al.
Publicado: (2021)

Lower Risk of Cardiovascular Events in Adult Patients with Chronic Hypoparathyroidism Treated with rhPTH(1–84): A Retrospective Cohort Study
por: Ayodele, Olulade, et al.
Publicado: (2022)

Serum PTH levels in dialysis: better safe than sorry
por: Cozzolino, Mario, et al.
Publicado: (2020)

A Study Of K- N Interactions In The Center-of-mass Energy Range From 1.60-gev To 1.75-gev
por: Hepp, V, et al.
Publicado: (1976)

Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients
por: Einbinder, Yael, et al.
Publicado: (2017)

Elastic scattering of anti-protons on polarized protons at 1.75, 2.15 and 2.40 GeV/c
por: Daum, C, et al.
Publicado: (1967)

Large Spin Hall Conductivity and Excellent Hydrogen Evolution Reaction Activity in Unconventional PtTe(1.75) Monolayer
por: Shao, Dexi, et al.
Publicado: (2023)

Risk of Chronic Kidney Disease in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort
por: Gosmanova, Elvira, et al.
Publicado: (2021)

Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study
por: Ayodele, Olulade, et al.
Publicado: (2022)

The AC Soft Magnetic Properties of FeCoNi(x)CuAl (1.0 ≤ x ≤ 1.75) High-Entropy Alloys
por: Wu, Zhongyuan, et al.
Publicado: (2019)

OR07-01 Identification of the First Case of Acquired Autoimmune Parathyroid Hormone (PTH) Resistance Due to PTH1 Receptor (PTH1R) Autoantibodies
por: Mandl, Adel, et al.
Publicado: (2020)

Differential temporal profile of lowered blood glucose levels (3.5 to 6.5 mmol/l versus 5 to 8 mmol/l) in patients with severe traumatic brain injury
por: Meier, Regula, et al.
Publicado: (2008)

TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
por: Yamrozik, June A, et al.
Publicado: (2009)

1Q84 /
por: Murakami, Haruki, 1949-
Publicado: (2012)

Disruption of PTH Receptor 1 in T Cells Protects against PTH-Induced Bone Loss
por: Tawfeek, Hesham, et al.
Publicado: (2010)

Crystal structure of apatite type Ca(2.49)Nd(7.51)(SiO(4))(6)O(1.75)
por: Le, Thu Hoai, et al.
Publicado: (2016)

Decrease in the expression of the type 1 PTH/PTHrP receptor (PTH1R) on chondrocytes in animals with osteoarthritis
por: Becher, Christoph, et al.
Publicado: (2010)

Bis[6-(3,5-dimethyl-1H-pyrazol-1-yl)picolinato-κ(2) N (1),O (2)]cadmium(II) 1.75-hydrate
por: Kai, Zhao, et al.
Publicado: (2008)

Poly[[μ(2)-aqua-tetraaquahexakis(μ(4)-naphthalene-2,6-dicarboxylato)tetraholmium(III)] 1.75-hydrate]
por: Almeida Paz, Filipe A., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_trd9fbosghcahlm460tkosqbjb